Clinical Trials Browser

Phase 2 × Carcinoma, Ovarian Epithelial × irofulven × Clear all

NCT00053365 2019-07-24

Irofulven in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal Cancer

Phase 2 Completed

61 enrolled 10 charts

Carcinoma, Ovarian Epithelial

NCT00019552 2013-06-20

Irofulven in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer

Phase 2 Completed

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms